Phibro Animal Health will acquire product portfolio from Zoetis

    The $350 deal includes medicated feed additive products, certain water soluble products, and related assets.
    Photo: Jonatan Rundblad/Adobe Stock
    Phibro Animal Health will acquire Zoetis’ medicated feed additive (MFA) product portfolio, certain water soluble products and related assets for $350 million. The 2 parties announced the definitive agreement on Sunday, April 28, 2024, in a joint news release.
    The product portfolio is comprised of more than 37 product lines that are sold in ap
    This post WAS generated by Author with the help of AI .

    DVM360 is the official website for the renowned veterinary publication dvm360® magazine. As a giant in the industry, dvm360 provides veterinary professionals with comprehensive resources and information to help enhance patient care and client services. We cover every angle of veterinary medicine from recent technological advancements to clinical insights to effective managerial strategies.

    Latest articles

    Related articles

    Leave a reply

    Please enter your comment!
    Please enter your name here